Author: trainitright

It’s Not Just About Snoring;

Sleep Apnea Can Prove Fatal

Many people may think sleep apnea is just an inconvenience for those who are afflicted with the condition. Others may think it is unfortunate for those forced to listen to their partner’s snoring.

But sleep apnea also can be lethal.

“A person can go for weeks without food, days without water, but only minutes without air,” says Dr. Daniel Klauer, DDS, author of Achieve Your Victory: Solutions for TMD and Sleep Apnea  (www.drdanielklauer.com).

“Waking up gasping for air is more than an inconvenience; it can be life-threatening. People who have sleep apnea should not shrug it off as something minor.’’

Actress Carrie Fisher’s death was attributed – at least in part – to sleep apnea. Other celebrities with sleep apnea listed as a contributing factor in their deaths include actor John Candy, rock star Jerry Garcia and NFL player Reggie White.

Klauer says disturbances in sleep bring decreased levels of oxygen to the brain, which can lead to a host of health issues such as heart disease, hypertension and diabetes.  A 15-year study of more than 10,000 adults, published in the Journal of the American College of Cardiology, also found strong links between sleep apnea and cardiovascular diseases.

Deaths from sleep apnea alone are not common, but sleep apnea elevates the risk of dying from other issues.  People with untreated sleep apnea are more likely to have a heart attack; have a higher risk of having a stroke; and have three times the risk of a premature death. One study showed that 42 percent of the deaths in sleep apnea patients were due to heart disease.

Klauer says there are four signs someone could suffer from sleep apnea:

 

  • Snoring. Approximately 35 percent of married couples sleep in separate bedrooms due to snoring.  Snoring isn’t always a sign of sleep apnea, Klauer says, but it is typically one of the symptoms.  If snoring is accompanied with choking or gagging sounds through the night, then the sleeper is experiencing sleep apnea.
  • Patient stops breathing during sleep. Sleep apnea sufferers stop breathing 30 or more times an hour for a minimum of 10 seconds or more at a time. The interruptions in sleep lessen the oxygen flow to the brain, and the brain doesn’t function well on low oxygen.
  • Day fatigue. Most victims of sleep apnea report feeling tired most of the time.   And since a person with sleep apnea typically has shallow breathing or wakes up constantly, in addition to being tired during the daytime, they are also usually drowsy and irritable – which are symptoms of somebody who is simply not getting enough sleep.
  • Teeth grinding. This is the condition known as bruxism.  Sleep apnea sufferers may awake with sensitive teeth or tight jaw muscles, Klauer says.  It happens because the breathing airway is obstructed. According to the National Sleep Foundation, one in four people with obstructive apnea grind their teeth.

“Too many people may think their partner’s snoring is just an inconvenience, so they move into the next bedroom and think the problem is solved,” says Klauer.  “Many times, the person who suffers from sleep apnea just gets used to the snoring and waking in the middle of the night.  So once their partner moves into another bedroom, they stop taking it seriously. But to ignore those symptoms and not talk to your doctor could be a fatal mistake.”

 

About Dr. Daniel Klauer, DDS

Dr. Daniel Klauer, DDS, is author of Achieve Your Victory: Solutions for TMD and Sleep Apnea (www.tmjsleepindiana.com). Since 2013, Dr. Klauer has limited his practice to treating patients with craniofacial pain, TMD, and sleep breathing disorders. Dr. Klauer is board certified with the American Board of Dental Sleep Medicine, American Board of Craniofacial Pain, and the American Board of Craniofacial Dental Sleep Medicine. He is diplomate eligible with the American Board of Orofacial Pain. He attended the University of Notre Dame and was a member of the Big East Championship Varsity Golf Team. After graduating from the University of Notre Dame, Dr. Klauer earned his doctor of dental surgery degree (DDS) from Ohio State University.

Namaste The Hard Way: A Daughter's Journey to Find Her Mother on the Yoga Mat  By Sasha Brown-Worsham

"A moving, profound story about the love between mothers and daughter and what they share, even after death. You definitely don't have to have even stepped foot in a yoga studio to appreciate this story. It's the kind of book that stays with you long after you finish and make you want to hold the people you love even closer.” − Mandy Stadtmiller, Author of Unwifeable

"My mother used to chant in Sanskrit in her study before sunrise every morning. Though she died when I was 16—22 years ago—I always hear her voice that way. Off-key, but strangely hypnotic, the language both complicated and pure, reverberating around our house.”
– from Namaste the Hard Way

Deerfield Beach, FL, September 24, 2018 — While other moms were at Bible study, Sasha Brown-Worsham's mom was studying Sanskrit; while others were finding friendship at Tupperware parties, her mom was finding enlightenment at the ashram. It wasn't until she was gone that Brown-Worsham began to appreciate her mother's bravery and the profound role that yoga would play in her adult life. In Namaste the Hard Way: A Daughter's Journey to Find Her Mother on the Yoga Mat, Brown-Worsham deftly captures the universal experience of the mother-daughter bond, teenage angst, and coming of age while sharing the life skills learned in her journey to becoming a Yogi.

This is not your mother's yoga book. The author writes with the heartfelt humor of a teenage girl going through loss, love, and self-discovery. As a rebellious child with a racing mind, Brown-Worsham takes us through the wisdom she learned from the guidance and loss of her passionate, yoga-practicing mother who was taken too soon by breast cancer.

After her mother's death, Brown-Worsham ran as far away from yoga as she could until a running injury left her needing the very thing she was running from. It was there—on the mat— that she processed her grief and found her mother again. In the space of her yoga mat, she and her mother connect across time.

According to ancient Indian philosophy, Sanskaras are the thought patterns and scars that arise from our personal pain. In Namaste the Hard Way, pain and self-discovery are brilliantly paired with the grounding teachings of yoga. Inhalations help us strengthen and embolden. Exhalations help us surrender and accept. Every posture is a metaphor, every class an opportunity to see with new eyes. The story of adolescence is one that we can all resonate with, and the teachings of yoga offer us guidance, wisdom, and strength.

About the Author:

Sasha Brown-Worsham is a writer, editor and yoga teacher whose work has been featured in The New York Times, Cosmopolitan, Redbook, Boston Globe, and countless other publications. She was the lifestyle editor at both Cafe Mom and She Knows Media for many years and was also a staff writer at both publications. Currently, she is a contracted writer for Destination America's blog, The Hauntist. She has written on everything from haunted corn fields to Bernie Sanders to onesies and SUP Yoga.

Namaste the Hard Way: A Daughter's Journey to Find Her Mother on the Yoga Mat
By Sasha Brown-Worsham
HCI Books
ISBN-9780757320606
$15.95
September 2018
Available wherever books are sold or to order directly from the publisher, contact: (800) 441-5569 or www.hcibooks.com

Golden Leaf Holdings’ Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada

 

TORONTO – September 24, 2018 – Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced its 100 percent-owned Canadian subsidiary Medical Marijuana Group Corporation (“MMG”), a Licensed Producer in St Thomas, Ontario received its Sales License from Health Canada on Friday September 21, 2018. The news is a significant milestone for the Canadian LP.

 

Asked for comment, President of MMG Phillip Millar said, “We are thrilled with the news. All of our product in inventory will move immediately to buyers and could contribute approximately US$900,000 to third quarter GLH revenue. All 2018 product we can grow is already pre-sold under very favourable wholesale pricing.  Our plan for 2019 is to secure direct-to-customer licensing and supply the profitable medical patients’ market with the assistance of our sister company MMC, also 100 percent-owned by GLH, which currently has patient lists that can account for 100 percent of our production capacity. We expect the complete value chain of seed to consumer will result in high profit margins.

 

Today, we have one of Canada's most advanced indoor grow operations with exceptional yields and preeminent cannabis products. Now that the sales license has been approved, we are able to ship our top-quality product to a waiting wholesale buyer. Numerous new orders are now being received on a daily basis. We want to leverage this momentum to stay focused on achieving profitability and creating value for shareholders.”

William Simpson, CEO of Golden Leaf Holdings, commented, “We anticipate this news to contribute to our third quarter revenue numbers and foster increased investor confidence in our company.  With recreational cannabis becoming legal in Canada in the fourth quarter of 2018, we are well situated to take advantage of anticipated product demand in an exciting market.  This accomplishment is the first of many steps that establishes us as an international cannabis company.”

When asked about next steps, Mr. Millar replied, “MMG has submitted Building Permit applications with the St. Thomas Municipality for expanded space to allow for cannabis oil and edibles production. Indications are that the Canadian Government will approve the production and sale of such products about a year from now. MMG expects to be able to leverage Golden Leaf’s existing capabilities with these products that it currently produces and sells on the west coast of the United States.”

To be added to the distribution list please email ir@goldenxtrx.com with “GLH” in the subject line.

 

About Golden Leaf Holdings

Golden Leaf Holdings Ltd. is a Canadian company with operations in multiple jurisdictions including Oregon, Nevada and Canada, with cultivation, production and retail operations built around recognized brands. Golden Leaf distributes its products through its branded Chalice Farms retail dispensaries, as well as through third-party dispensaries. Golden Leaf’s cannabis retail operations and products are designed with the customer in mind, focused on superlative in-store experience and quality products. Visit goldenleafholdings.com to learn more.

New Poll: Canadians Strongly Agree that Access to Affordable Prescription Medicines is Most Important Priority for NAFTA 2.0

 

TORONTO, Sept. 24, 2018 /CNW/ - A new poll confirms that Canadians do not want their access to generic and biosimilar medicines traded away under a new NAFTA deal.

There are several proposals on the table in the NAFTA negotiations that would require changes to Canada's laws and delay when lower-cost generic and biosimilar drugs can enter the market. This includes longer periods of data protection for expensive biologic drugs. If Canada were to adopt the proposals, every single Canadian would be negatively impacted by the billions of dollars in additional drug costs created through delayed access to generic and biosimilar medicines.

The poll found that Canadians feel that access to more affordable prescription medicines is much more important than any other area of negotiation that has dominated the media coverage of the NAFTA negotiations – including supply management system for agricultural products, automotive issues, exemptions for cultural industries and investor-state dispute resolution.

Canadians feel that NAFTA 2.0 should increase access to generic and biosimilars medicines. Canadians believe that access to affordable prescription medicines is the most important outcome of NAFTA 2.0, and four in five feel that it's important that NAFTA revisions should not delay Canadians access to more affordable versions of expensive biologic drugs. Four in five Canadians also say it's important that NAFTA 2.0 not create new barriers for the implementation of National Pharmacare in Canada.

Two in three Canadians say it is very important that NAFTA 2.0 does not increase prescription drug costs, delay access to affordable drugs or limit the options of prescription drug coverage.

More than 80 per cent of Canadians say it's important that NAFTA 2.0 put Canadians' access to affordable prescription drug coverage ahead of the profits of brand-name drug companies based in the United States.

"This poll confirms that Canadians do not support any concessions in a new NAFTA that will delay their access to more affordable generic and biosimilar medicines," said Jim Keon, President of the Canadian Generic Pharmaceutical Association. "The CGPA urges the Government of Canada to stand firm and not trade away timely access to generic and biosimilar medicines in a new NAFTA.

"Any such concessions would be harmful to Canadians, harmful to our industry and provide an enormous gift to the brand-name pharmaceutical industry – an industry that already enjoys some of the highest prices in the world for their products and some of the world's most favourable IP laws, while making virtually no investments in Canada."

About the Poll

The poll was conducted by Morning Consult for the Canadian Generic Pharmaceutical Association from September 14-16, 2018, among a sample of 2,203 Adults. The interviews were conducted online and the data were weighted to approximate a target sample of Adults based on age, race/ethnicity, gender, educational attainment and region. Results from the full survey have a margin of error of plus or minus two percentage points. To learn more about the poll, please visit www.canadiangenerics.ca/newnafta/

About the Canadian Generic Pharmaceutical Association

The Canadian Generic Pharmaceutical Association (CGPA) represents Canada's generic pharmaceutical industry. The industry plays an important role in controlling health-care costs in Canada. Generic drugs are dispensed to fill more than 71 percent of all prescriptions but account for account for only 21 percent of the $28-billion Canadians spend annually on prescription medicines:

SOURCE Canadian Generic Pharmaceutical Association

Weight Watchers Becomes WW, Reinforcing Its Mission to Focus on Overall Health and Wellbeing

 

Introduces New Tagline: "Wellness That Works.TM"

WW App to Provide Enhanced Digital Experiences and First of Its Kind "WellnessWinsTM" Member Rewards Program Launching October 4

NEW YORK, Sept. 24, 2018 /CNW/ - To reflect the next stage of the company's evolution to focus on overall health and wellness, Weight Watchers International, Inc. (NYSE: WTW) today announced that the company will become WW, honoring its legacy while broadening the role it plays in helping everyone live healthier lives. A new tagline, "Wellness that Works.TM" will be used globally to reflect the company's heritage and overall approach to health and wellbeing of inspiring powerful habits rooted in science.

"We are committed to always being the best weight management program on the planet, but now we're putting our decades of knowledge and expertise in behavioural science to work for an even greater mission," said Mindy Grossman, President and Chief Executive Officer, WW. "We are becoming the world's partner in wellness. No matter what your goal is – to lose weight, eat healthier, move more, develop a positive mind-set, or all of the above – we will deliver science-based solutions that fit into people's lives. This is just the beginning of our journey to become the world's partner in wellness, and I am inspired by the potential for our impact."

"From the moment I chose to invest in the company and join the Board, I have believed that the role WW can play in people's lives goes far beyond a number on the scale," said Oprah Winfrey. "As Weight Watchers becomes WW, I believe we will continue to inspire people not only to eat well, but to move more, connect with others and continue to experience the joys of a healthy life."

Enhanced Digital Experience with More Holistic Focus on Wellness
To become a true partner in wellness, WW is evolving all aspects of how it is integrated in people's lives. As a technology experience company, WW is continuously innovating and has made several enhancements to the digital experience, from partnerships in voice and mindset to new and enhanced tools focused on activity tracking and community building. The WW app, used by millions of WW members around the world, will be updated on October 4 to reflect the new brand identity. The following updates will be phased launches, beginning on October 4:

WellnessWinsTM
To inspire healthy habits, WW announced today that it will launch WellnessWins, a first-of-its-kind program that rewards members for small, everyday behaviors that are proven to lead to healthier habits. Members will earn "Wins" for tracking meals, activity and weight, as well as for attending WW Wellness Workshops. Wins can be redeemed for exclusive products, services and experiences designed to inspire members on their wellness journeys. Results from a pilot program showed increased engagement, satisfaction and retention. The program has been operating in beta and will launch to all members in Canada this December 2018, with launches in all international markets following in the first quarter of 2019.

Partnership with Headspace®
Mindset is an essential part of overall wellness, and WW has formed a partnership with Headspace, a global leader in meditation and mindfulness, to help develop customized content for WW members. An initial pilot in the U.S. embedding Headspace in the WW app showed a positive response. Content from Headspace will launch initially in English as part of the WW member experience and will later be offered in German and French – marking the first time that Headspace is creating content in a language other than English.

FitPoints® 2.0
Based on the latest science, WW will introduce an evolution of the FitPoints® system to encourage activity choices based on what will have the greatest impact on an individual's health and wellness. The new FitPoints® will be personalized to each individual within the WW app – based on their height, weight, age and sex – so members know exactly what each activity is worth to them. Just as all calories are not created equal, the same is true for activities: 100 calories burned walking is not the same as 100 calories burned lifting weights or running. And so the new algorithm encourages members to include high intensity and strength training in their activity plans, but still provides the ability to earn FitPoints® for all types of activities. Updated FitPoints® will be available in the WW app globally in December.

Connect Groups
WW is launching Connect Groups, a new way to strengthen WW's community and help foster meaningful relationships that inspire healthy habits. Community is one of the most powerful parts of the WW experience and an important element of wellness. Groups will deepen WW's Connect community in the app, which currently has on average 1.8 million unique users each month, by helping people to find other members like them, based on:

  • Food (e.g., gluten-free, vegetarian, foodies)
  • Life Stages (e.g., college students, new moms, brides/grooms, 20-somethings)
  • Wellness Journey (e.g., newbies, maintaining)
  • Activity (e.g., running, yoga, swimming, new to activity)
  • Mindset (e.g., gratitude, mindfulness, self-compassion)
  • Hobbies (e.g., hiking, traveling)

Connect Groups will be available globally by December.

Healthy Habits Focus in App
WW will launch a healthy habits focus for members, which will make the program open to those who want to build healthy habits without focusing on weight loss. These members will have access to all the tools WW offers, including WW Freestyle to guide healthier food choices, FitPoints to become more active, community through Connect and content to help develop a positive mindset, and the new WellnessWins rewards program.

Voice Integration with Amazon Alexa and the Google Assistant
Today, WW is launching a beta version of voice integration with Amazon Alexa and the Google Assistant, which will enable WW members to use their voices to:

  • Easily look up SmartPoints values for their food
  • Get updates on their progress on their daily SmartPoints
  • Easily track foods
  • Quick-add SmartPoints to their tracker (e.g., "Add 5 Points to my lunch.")

A U.S. launch is planned for late Fall and will expand globally thereafter.

WW Products
In a further move toward wellness, starting in January 2019, every product sold directly to consumers by WW globally will have no artificial sweeteners, flavours, colours and preservatives and will reflect the new brand identity, instantly signaling this new reformulation and development to consumers.

New Brand Identity and Launch
The move to WW includes an entirely new brand identity – from logo and colour palette to font and photography style – which will come to life across all brand touchpoints and member experiences leading with an all new WW app experience. A campaign launching the new brand will debut in late December and workshop locations will be refreshed in 2019.

"We will communicate the new articulation of the WW brand in many ways, one of the most important being our visual identity," said Gail Tifford, Chief Brand Officer, WW. "We listened to both our current and prospective members and created a new look and feel that is bold, strong and modern. It expresses the role we want to play in people's lives in becoming the world's partner in wellness."

About WW
WW is a global wellness company and the world's leading commercial weight-management program. We inspire millions of people to adopt healthy habits for real life. Through our engaging digital experience and face-to-face group workshops, members follow our livable and sustainable program that encompasses healthy eating, physical activity, and a positive mindset. With more than five decades of experience in building communities and our deep expertise in behavioral science, we aim to deliver wellness for all. To learn more about the WW approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

SOURCE Weight Watchers International, Inc.

Canadian employers grapple with cannabis legalization; CIA delays commuted value standard

 

An in-depth look at these and other subjects are covered in the current issue of the Morneau Shepell News & Views

TORONTO, Sept. 24, 2018 /CNW/ - Morneau Shepell released the September 2018 issue of its monthly newsletter, News & Views, in which the Company looked at a number of topics including: the expected impact of Canada's recreational cannabis legalization in the workplace, Morneau Shepell's launch of internet-based cognitive behavioural therapy, a delay in the Canadian Institute of Actuaries' new commuted value standard, and more.

  • Preparing employees for cannabis legalization – On October 17, 2018, Canada will legalize the distribution, access to and use of recreational cannabis, resulting in a level of uncertainty among Canadians. Leading up to cannabis legalization, there is an onus on employers to review existing workplace policies and procedures to prepare for potential issues and communicate changes to employees. Concerns that employers should prepare for include safety in the workplace, ensure workplace policies address recreational cannabis use, providing accommodation for medical cannabis, testing for impairment, providing support in cases of substance abuse within the organization and updating health benefit plans to address medical cannabis coverage.
  • Morneau Shepell launches internet-based cognitive behavioural therapy platform – Morneau Shepell has launched internet-based cognitive behavioural therapy (iCBT), a new digital platform addressing the growing need for mental health resources in Canada. Cognitive behavioural therapy has been proven effective for dealing with mental health problems including depression, chronic pain, eating disorders, anger, addiction and low self-esteem. Morneau Shepell's iCBT allows users to access online counselling in real-time through a blended approach of counsellors and the online platform, providing tailored programs to address each individual's specific needs. iCBT targets gaps in mental health treatment available from public and private sources, which in turn reduces absenteeism and shortens return to work time frames.
  • Advisory Council issues discussion paper on national pharmacare model – The Advisory Council on the Implementation of National Pharmacare released a discussion paper on the options for a national pharmacare model, seeking input from Canadians to be used in a report presented to the Minister of Finance and Minister of Health in 2019. The report requests public input on three main issues: who will be covered and under what circumstances, which drugs will be covered and how the model will be financed.
  • New studies examine Canadians' retirement planning perceptions – Recent studies conducted by the Canadian Institute of Actuaries (CIA) and the Ontario Securities Commission (OSC) looked into the perceptions and behaviours of Canadians regarding the financial aspects of retirement planning. In its study, the CIA found that retired and nearly retired Canadians misunderstand aspects of retirement planning, potentially leading to a harmful impact on their financial wellness. The OSC survey analyzed how behavioural insights could be leveraged to offer new initiatives and strategies that plan sponsors could use to help plan members overcome challenges in creating personal financial plans for retirement.
  • CAPSA releases draft revised Defined Contribution Pension Plans Guideline – On July 26, 2018, the Canadian Association of Pension Supervisory Authorities (CAPSA) issued a draft revised version of Guideline No.8 – Defined Contribution Pension Plans Guideline. Key changes to the guideline include a more detailed discussion of the risk factors and other relevant factors in choosing investment options; suggestions that fees should be disclosed on each annual statement and termination statement; and that increased fees applicable to members could constitute an adverse amendment in some jurisdictions.
  • CIA announces delay in commuted value standard – On July 26, 2018, the Canadian Institute of Actuaries (CIA) announced a delay in its new commuted value standard, which is now expected to be implemented no sooner than the second calendar quarter of 2019. The delay follows a move toward increased focus on the long-term sustainability of defined benefit pension arrangements and less emphasis on short-term benefit security. This delay will disappoint some defined benefit pension plan administrators who were hoping for reduced commuted value payouts under the new standard.
  • Tracking the funded status of pension plans as at August 31, 2018 – Morneau Shepell shared the changes in the financial position of a typical defined benefit plan with an average duration since December 31, 2017. The graph in the newsletter shows the impact of three typical portfolios on plan assets and the effect of interest rate changes on solvency liabilities of medium duration.
  • Impact on pension expense under international accounting as at August 31, 2018 – Morneau Shepell showed the expense impact for a typical pension plan that starts the year at an arbitrary value of 100 (expense index). Since the beginning of the year, the pension expense has decreased by 5 per cent (for a contributory plan) due to an increase in discount rates.

About Morneau Shepell
Morneau Shepell is the only human resources consulting and technology company that takes an integrated approach to employee well-being, health, benefits and retirement needs. The Company is the largest administrator of retirement and benefits plans and the largest provider of integrated absence management solutions in Canada. LifeWorks by Morneau Shepell is a total well-being solution that combines employee assistance, wellness, recognition and incentive programs. As a leader in strategic HR consulting and innovative pension design, the Company also helps clients solve complex workforce problems and provides integrated productivity, health and retirement solutions.  Established in 1966, Morneau Shepell serves approximately 24,000 clients, ranging from small businesses to some of the largest corporations and associations.  With more than 4,500 employees in offices across North America, Morneau Shepell provides services to organizations around the globe. Morneau Shepell is a publicly-traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit morneaushepell.com.

SOURCE Morneau Shepell Inc.

The Death Of The Angry Black Woman Invites Self-Reflection; Helps Women Learn How To Bury Their Anger And Embrace A New Self  

Charlotte, NC, September 21, 2018 ― Charlotte pastor and face of the popular Car Chronicles Movement, Jameliah Young-Mitchell has penned The Death of the Angry Black Woman—a book published by Warren Publishing that discusses stereotypes faced by African-American women. The book released at #1 on Amazon.com for New Releases in the Anger Management category.

Anger can get the best of many women, but when anger erupts into rage and leads to shouting, fighting, and name-calling, it's time to look within and make a change. The Death of the Angry Black Woman boldly acknowledges stereotypes faced by women in the black community and uncovers the seeds that lead many to live anger-filled lives. Instilled with Biblical scripture and jaw-dropping honesty, this debut book from Pastor Jameliah Young-Mitchell, the voice behind the popular Car Chronicles Movement, will empower you to bury your anger, reject false labels, and embrace the new you.

"I wrote this book for all the women out there who are dealing with anger that they have yet to find the source of,” said Young-Mitchell. "Many women in the black community come from backgrounds of abuse, mistreatment, violence––and they become fighters. Through my book I hope to be that voice in their head, the one we all hear but rarely acknowledge, encouraging them to move on, let go of anger, reject hateful labels, embrace their powerful femininity, and live the life God intended them to live.”

Pastor Jameliah Young-Mitchell is the daughter of the late Evangelist Violetta B. Young and Pastor James I. Young, and grew up in Brooklyn, NY, as the youngest of four kids. She has preached across the United States and internationally and is the pastor of Unity Church Charlotte. Young-Mitchell is an experienced keynote speaker for women's empowerment, teen and youth mentoring, corporate America, and relationships. She is the voice behind the popular Car Chronicles Movement where she can be seen live on Facebook Monday through Friday at 7:30 a.m. Young-Mitchell is the proud mother of a son and daughter and resides in Charlotte, NC, with her husband, Calvin W. Mitchell.

The Death of the Angry Black Woman is available at warrenpublishing.net, Amazon.com, or wherever books are sold. Jameliah Young-Mitchell is available for book signings and interviews.

The Death of the Angry Black Woman
978-1943258-92-5
Released: July 2018
Soft Cover
$15.00

###

TIP SHEET:

Select excerpts from many five-star reviews on Amazon.com:

"This book is an awesome read! The transparency and life examples of Pastor Jameliah Young- Mitchell gives [sic] the reader a firsthand view of what an overcomer looks like. There is something for everyone to learn and apply to their lives to become better people.”

"At first I wasn't interested in reading this book because I felt that I was not 'Angry' but as I read I discovered that I was angry and suffered some of the same things but learned how to mask the pain. This book allowed me to begin the process of a new me. I highly recommend this book to anyone that is in need of refocusing.”

"I recently joined a book club with a few other ladies and this was one of the first books recommended. I could relate to a lot of the content in the book and was able to dig a little deeper and have a little self-reflection afterwards. I highly recommend this!”

"I liked everything about the book. From the start to the end... it's a mind-blowing moment for real I tell you! This is a 10-star book.”

"This book is just awesome. It has definitely set me free, it has been a blessing to My Mind & Soul.”

"[Jameliah] is very candid in this book. She has a way of leading, teaching, and encouraging, all while openly acknowledging that she too is still learning. It is written in such a way that EVERYBODY can understand. I love it!!”

A User’s Guide to Cheating Death begins streaming on Netflix on September 28; Season Two premieres on VisionTV October 15 -
September 21, 2018, Toronto, Canada– From lunchtime injections to laser fillers, detoxing to holistic medicine, stem cell research and vaginal steaming. How much of it actually works, and is any of it harmful? On Friday, September 28, Netflix will begin North American-wide streaming of Season One of the provocative series, A User's Guide to Cheating Death, followed by the Season Two premiere on VisionTV on Monday, October 15 at 9 pm ET in Canada. Produced by Toronto-based Peacock Alley Entertainment, each one-hour episode of the docu-series challenges mass-marketed health trends often fuelled by celebrity pop culture.

Hosted by Canadian professor, health expert, author, and debunker extraordinaire, Timothy Caulfield (known for his book Is Gwyneth Paltrow Wrong About Everything?) uses his trademark humour, quick wit and authoritative science knowledge to investigate trendy diets, ancient therapies, wellness and anti-aging products to separate science fact from fiction.
Believing that to bust the myth, you must first understand it, Caulfield follows the latest fads and trends to their origins around the world meeting with new users and devotees who swear by the treatments before signing up for the bizarre procedures himself. He risks his health and personal safety to communicate one simple and important idea – staying healthy should not be this complicated!

“We felt there was an appetite for a show like this right now because there is so much noise out there about health that is given a veneer of science. If it is marketed as scientific, I think it is legitimate to critique it using science with an informed, open-minded and fun approach that offers different perspectives,” says Caulfield.

The first season covers everything from the current trend of detoxification cleansing, the strange, fascinating and unregulated world of the anti-aging industry; direct-to-consumer genetic testing; weight loss obsessions, and more. Season Two will delve deeper to examine sex and relationships, body hacking, germs, and spiritual science.

“The anti-aging industry is worth almost $200 billion a year. People want to live forever and look good doing it. We are providing a resource for audiences around the world to help discern fact from fiction that will shine a light on the good advice out there regarding health and anti-aging/look better trends vs the bad,” said Carrie Mudd, Executive Producer, Peacock Alley Entertainment.

Last month, Peacock Alley Entertainment announced a deal with Sky Vision for the distribution rights to Season Two of A User’s Guide to Cheating Death. Season One has been an international hit that premiered first on VisionTV in Canada last fall. Since then, is seen in 67 territories including Australia, New Zealand, Russia, Africa, India, much of Europe and the Far East. It has been picked up by SBS Australia, TV New Zealand, Societe Radio-Canada, Telefonica in Spain, DR in Denmark, BBC Worldwide, UR Sweden, TVB in Hong Kong, S+ in Portugal, Ananey in Israel and AMC in Central Europe.

About Peacock Alley
Peacock Alley Entertainment is a proven producer of successful, critically acclaimed scripted and unscripted content for channels around the globe. From inception to execution, our focus is storytelling. Productions include Travelers (Netflix), A User’s Guide to Cheating Death (BBC Worldwide & Vision), Tower of Song: Leonard Cohen (CBC & PBS), Taste Testers (Food Network), Unusually Thicke (Pop), Brave New Girls (E!), Illusions of Grandeur (OLN), Money Moron (Slice) and Sweat the City (Z Living).

Season III of Travelers premieres this year, starring Eric McCormack, MacKenzie Porter, Nesta Cooper, Jared Abrahamson, Reilly Dolman and Patrick Gilmore. Peacock Alley is currently in production on the North American adaptation of the Emmy Award-winning Channel 4 format 50 Ways to Kill Your Mammy. Slated for production this winter is the true crime comedy New Eden, the feature-lengthdocumentary Disorganized Sport that follows skateboarding to the 2020 Olympics, and the sex and science documentary series Jensplaining.
SAMHSA awards $61.1 million in suicide prevention funding
The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced it has awarded up to $61.1 million in grants to be disbursed over several years for suicide prevention programs.

September is National Suicide Prevention Awareness Month, during which the mental health community across the nation raises awareness and resources for suicide prevention. The National Suicide Prevention Lifeline (1-800-273-8255) is a nationwide network of crisis centers that provides immediate help to people in crisis. SAMHSA awards grants to support the Lifeline and many other suicide prevention activities.

SAMHSA has long served a leading role in efforts to reduce suicide among people of all age groups, providing a range of services in a variety of settings. “Suicide is an urgent public health issue, and we are directing resources to help people when they need it most,” said Assistant Secretary for Mental Health and Substance Use Elinore F. McCance-Katz, MD, PhD.

The grant programs included in this effort are:

The National Suicide Prevention Lifeline and Disaster Distress Helpline

The Helpline is funded at $6.1 million annually through a grant to the Mental Health Association of New York City. The 2018 grant award continues funding for three years, totaling more than $18 million.

The Garrett Lee Smith Campus Suicide Prevention Grant

This grant is designed to:

  • develop approaches to improve mental health services for college students,
  • reduce the impact of mental and substance use disorders in young American adults,
  • encourage students to seek help when needed, and
  • identify and treat those who may need help for mental or substance use disorders.

Up to 20 institutions of higher education will receive Garrett Lee Smith grants for as much as $102,000 per year for three years, for a total of $5.8 million.

List of grantees

Zero Suicide

The Zero Suicide grant program helps to implement suicide prevention and intervention programs within health systems for adults age 25 or older. Up to 14 grantees will receive as much as $700,000 per year for five years, for a total of $37 million.

List of grantees

The actual award amounts may vary, depending on the availability of funds. Information on SAMHSA grants is available at: http://www.samhsa.gov/grants.

For questions or further information about these grant programs, please contact SAMHSA’s Division of Grants Management at 240-276-1400.
###
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus

 

TRESIBA® is the first insulin added to Health Canada's Register of Innovative Drugs

Manitoba to reimburse Tresiba® following Ontario listing

MISSISSAUGA, ON, Sept. 21, 2018 /CNW/ - Novo Nordisk Canada Inc. announces that Ontario will now reimburse TRESIBA® (insulin degludec injection) FlexTouch®prefilled pen in both 100 units/mL and 200 units/mL doses, as a general benefit for people living with Type 2 and Type 1 diabetes. TRESIBA® is an ultra-long-acting basal insulin, for adults with diabetes mellitus, and will now be reimbursed under the Ontario Drug Benefit program, effective September 27, 2018.1,2

In addition, the Government of Manitoba also announced that it will reimburse TRESIBA® (insulin degludec injection) for both 100 units/mL and 200 units/mL doses under the Manitoba Drug Benefits and Interchangeability Formulary, effective October 18, 2018.3

"Having the ability to choose which insulin works best for them can have a great impact on how well people with diabetes are able to manage their blood sugar levels," says Dr. Jan Hux, President of Diabetes Canada. "The governments of Ontario and Manitoba have shown leadership by improving access to medications through the addition of a new insulin to their public drug program formularies, and we encourage the rest of Canada to do the same."

The addition of TRESIBA® to the Ontario Drug Benefit program and Manitoba Drug Benefits and Interchangeability Formulary represents an important milestone for people living with diabetes. Following its approval by Health Canada in August 2017, TRESIBA® became the first insulin added to the Register of Innovative Drugs for human use and has obtained its first provincial listing promptly after regulatory approval.

"We applaud the governments of Ontario and Manitoba for taking this important step in making innovative treatments more easily available to those living with diabetes in these provinces," says Dave Prowten, President and CEO, JDRF Canada. "When it comes to treatments that help people better manage their Type 1 diabetes, JDRF continues to support both access and choice."

About Tresiba®
Tresiba® (insulin degludec injection) is a once-daily, ultra-long-acting basal insulin approved in Canada on August 25, 2017 for the once-daily treatment of adults with diabetes mellitus to improve glycemic control.1 Tresiba® provides a duration of action beyond 42 hours with a flat and stable glucose-lowering effect.1,4 It has been shown to provide a lower risk of overall, nocturnal and severe hypoglycemia, and low variability in blood sugar levels versus insulin glargine U100.1,5 Tresiba® received its first regulatory approval in September 2012 and has since been approved in more than 80 countries globally. It is now commercially available in more than 61 countries.

Hypoglycemia is the most common adverse reaction of all insulin preparations, including Tresiba®. The most common side effects found with Tresiba® are hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema and weight gain.1

About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, hemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries. For more information, visit novonordisk.ca, Twitter, YouTube.

References

  1. Novo Nordisk Canada Inc. TRESIBA® Product Monograph. July 17, 2018. http://www.novonordisk.ca/content/dam/Canada/AFFILIATE/www-novonordisk-ca/OurProducts/PDF/tresiba-product-monograph.pdf. Accessed July 24, 2018.
  2. Ontario Drug Benefit Formulary/Comparative Drug Index. Edition 43. September 20, 2018. http://www.health.gov.on.ca/en/pro/programs/drugs/formulary43/summary_edition43_20180920.pdf. Accessed September 20, 2018.
  3. Bulletin #101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. September 20, 2018. http://www.gov.mb.ca/health/mdbif/docs/bulletins/. Accessed September 20, 2018.
  4. Haahr H, Heise T. A review of the pharmacological properties of insulin degludec and their clinical relevance. Clin Pharmacokinet. 2014; 53:787-800.
  5. Marso SP, McGuire DK, Zinman B, et al. Efficacy and safety of degludec versus glargine in type 2 diabetes. N Eng J Med. 2017. DOI: 10.1056/NEJMoa1615692.

SOURCE Novo Nordisk Canada Inc.